Home › Compare › CTCX vs ADC

CTCX vs ADC: Dividend Comparison 2026

CTCX yields 1013.68% · ADC yields 4.11%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CTCX wins by $21217096.95M in total portfolio value
10 years
CTCX
CTCX
● Live price
1013.68%
Share price
$0.20
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21217097.13M
Annual income
$17,768,877,895,719.51
Full CTCX calculator →
ADC
Agree Realty Corporation
● Live price
4.11%
Share price
$75.38
Annual div
$3.10
5Y div CAGR
40.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$176.9K
Annual income
$79,647.25
Full ADC calculator →

Portfolio growth — CTCX vs ADC

📍 CTCX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCTCXADC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CTCX + ADC cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
CTCX pays
ADC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CTCX
Annual income on $10K today (after 15% tax)
$86,163.20/yr
After 10yr DRIP, annual income (after tax)
$15,103,546,211,361.58/yr
ADC
Annual income on $10K today (after 15% tax)
$349.45/yr
After 10yr DRIP, annual income (after tax)
$67,700.16/yr
At 15% tax rate, CTCX beats the other by $15,103,546,143,661.42/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CTCX + ADC for your $10,000?

CTCX: 50%ADC: 50%
100% ADC50/50100% CTCX
Portfolio after 10yr
$10608548.65M
Annual income
$8,884,438,987,683.37/yr
Blended yield
83.75%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ADC right now

CTCX
No analyst data
Altman Z
-56.1
Piotroski
4/9
ADC
Analyst Ratings
1
Strong
22
Buy
9
Hold
Consensus: Buy
Price Target
$81.06
+7.5% upside vs current
Range: $75.00 — $84.50
Altman Z
1.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CTCX buys
0
ADC buys
0
No recent congressional trades found for CTCX or ADC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCTCXADC
Forward yield1013.68% ✓4.11%
Annual dividend / share$2.00$3.10 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.4% ✓
Portfolio after 10y$21217097.13M ✓$176.9K
Annual income after 10y$17,768,877,895,719.51 ✓$79,647.25
Total dividends collected$20954125.95M ✓$154.7K
Payment frequencyquarterlymonthly
SectorStockREIT

Year-by-year: CTCX vs ADC ($10,000, DRIP)

YearCTCX PortfolioCTCX Income/yrADC PortfolioADC Income/yrGap
1← crossover$112,068$101,368.47$10,987$577.21+$101.1K → CTCX
2$1,181,615$1,061,701.90$12,293$855.34+$1.17M → CTCX
3$11,726,249$10,461,920.38$14,088$1,290.70+$11.71M → CTCX
4$109,578,123$97,031,037.37$16,660$1,994.91+$109.56M → CTCX
5$964,654,833$847,406,240.94$20,525$3,181.85+$964.63M → CTCX
6$8,004,158,004$6,971,977,332.68$26,654$5,286.90+$8004.13M → CTCX
7$62,629,410,485$54,064,961,420.43$37,006$9,259.47+$62629.37M → CTCX
8$462,375,346,702$395,361,877,482.99$55,862$17,338.74+$462375.29M → CTCX
9$3,222,634,793,872$2,727,893,172,901.40$93,452$35,300.32+$3222634.70M → CTCX
10$21,217,097,125,163$17,768,877,895,719.51$176,931$79,647.25+$21217096.95M → CTCX

CTCX vs ADC: Complete Analysis 2026

CTCX — Stock

Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.

Full CTCX Calculator →

ADC — REIT

Agree Realty Corporation is a publicly traded real estate investment trust primarily engaged in the acquisition and development of properties net leased to industry-leading retail tenants. As of September 30, 2020, the Company owned and operated a portfolio of 1,027 properties, located in 45 states and containing approximately 21.0 million square feet of gross leasable area. The Company's common stock is listed on the New York Stock Exchange under the symbol ADC.

Full ADC Calculator →
📬

Get this CTCX vs ADC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CTCX vs SCHDCTCX vs JEPICTCX vs OCTCX vs KOCTCX vs MAINCTCX vs NNNCTCX vs EPRTCTCX vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.